Objective: Malnutrition is observed frequently in patients with in¯ammatory bowel disease (IBD). Knowledge of the nutritional status in patients with recently diagnosed IBD is limited. The aim of this study was to establish a comprehensive picture of the nutritional status in recently diagnosed IBD patients. Subjects: Sixty-nine IBD patients (23 Crohn's disease (CD) and 46 with ulcerative colitis (UC)) within 6 months of diagnosis and 69 age-and sex-matched population controls were included in the study. Methods: The nutritional status was assessed by: (1) body composition (anthropometry and dual-energy X-ray absorptiometry); (2) dietary intake (dietary history); (3) biochemical indexes of nutrition; and (4) muscle strength (isokinetic dynamometer). Results: Body weight and body mass index were signi®cantly lower in UC patients compared with controls. The mean daily intake of carbohydrates was signi®cantly higher in CD patients and the intakes of protein, calcium, phosphorus, and ribo¯avin were signi®cantly lower in UC patients compared with controls, respectively. Serum concentrations of several nutrients (b-carotene, magnesium, selenium and zinc) were signi®cantly lower in UC patients compared with controls. Serum vitamin B 12 concentration was signi®cantly lower in CD patients. Muscle strength did not signi®cantly differ between IBD patients and controls.
Introduction
In¯ammatory bowel disease (IBD) is a chronic in¯amma-tory disorder that involves the colon in ulcerative colitis (UC) and may involve any part of the entire gastrointestinal tract in Crohn's disease (CD). In these patients malnutrition is often reported, especially in CD patients with active disease (Harries & Heatley, 1983; Fernandez-Banares et al, 1989 Cristie & Hill, 1990; Janczewska et al, 1991; Stokes, 1992; Kuroki et al, 1993 , Royall et al, 1995 Teahon et al, 1995; Zurita et al, 1995; Ascue et al, 1997; Capristo et al, 1998) . In a recent study, we found several nutritional and functional de®ciencies in patients with longstanding CD, currently in remission (Geerling et al, 1998a, b) . It is known that malnutrition is associated with immune dysfunction (Gallagher & Daly, 1993; Grimble, 1994; Wan et al, 1989) and increased susceptibility to oxidative tissue damage (Halliwell, 1994) . Adequate nutritional support may be an important therapeutic tool in improving the nutritional status and attenuating the in¯ammatory process in these patients.
In chronic disease, the nutritional status is the result of various physiological and pathophysiological processes . It is therefore important to assess a comprehensive nutritional status, measuring body composition, dietary intake, biochemical indexes of nutrition, and functional indexes such as muscle strength (Geerling et al, 1998a, b) .
There is only one study, to our knowledge, regarding nutritional status in CD patients at initial diagnosis (Kuroki et al, 1994) . This study, however, was restricted to the assessment of vitamin E status. Hence, the knowledge about the comprehensive nutritional status of newly diagnosed IBD patients is very limited. This knowledge could be important, as achieving an optimal nutritional status may be bene®cial for the clinical course of the disease in recently diagnosed IBD patients. The aim of the present study was to assess the comprehensive nutritional status of recently diagnosed IBD patients and to compare this with the status of healthy controls.
Subjects and methods
The study protocol was approved by the Ethics Committee of the University Hospital Maastricht and all subjects gave their informed consent before the start of the study.
Subjects
Patients were recruited from the out-patient population of the Department of Gastroenterology of the University Hospital, Maastricht, Atrium Medical Center, Brunssum, and the Maasland Hospital, Sittard, all located in the south of the province Limburg in The Netherlands. The diagnosis of IBD was based on the criteria proposed by LennardJones (1989) . All patients who had been diagnosed with IBD (n 76) during the period June 1995 ± December 1997 were asked to participate in the study. Sixty-nine patients (23 CD, 46 UC) agreed to participate (91%). All patients (mean age 35.4 y AE 13.6) had been diagnosed within 6 months prior to entering the study. Patient characteristics are shown in Table 1 . In the group with UC patients three patients suffer from proctitis. Disease activity for CD patients was assessed according to the Crohn's disease activity index (CDAI) (Best et al, 1979) as well as by the concentration of C-reactive protein (CRP) at the time of the investigation. For UC patients, disease activity was assessed according to the Truelove and Witts' criteria and was graded numerically as 6 ± 19 corresponding to no disease activity, 20 ± 32 as having moderate disease activity and 32 ± 45 corresponding to severe disease (Truelove & Witts, 1955) . In addition, the concentration of CRP at the time of the investigation was assessed. Sixty-nine volunteers (mean age 35.4 y AE 13.7) participated in this study as controls. They were randomly selected from the patient population database of a general health care centre (three general practitioners) located in the same study area. The controls were age-and sex-matched with IBD patients (within 3 y of age). Subjects with a history of IBD were excluded.
Methods
All measurements, except the assessment of the dietary intake, were performed during one day after an overnight fast at the University Hospital Maastricht.
1. Body composition. Body composition was assessed using anthropometry and dual X-ray absorptiometry (DXA). Body height (BH) was measured to the nearest millimetre using a wall-mounted stadiometer, while body weight (BW) was measured using an electronic scale with a digital readout to an accuracy of 0.01 kg. Body mass index (BMI) was calculated from weight and height (kgam 2 ).
Body fat (BF), fat-free mass (FFM), percentage body fat (%BF) and total body bone mineral content (BMC) were determined using a dual X-ray absorptiometer (DPX-L, Lunar Corp., Madison, WI; using DPX-L 1.3 software, Mazess et al, 1990) . A total body scan over the entire length of a subject's body was performed. Any material that could attenuate the X-ray beam, eg jewellery, watches or clothing with zippers, was removed before the examination.
2. Dietary intake. Dietary intake was assessed using the cross check dietary history (Beal, 1967) . The subjects were visited at home by an experienced dietician and the usual food consumption of the previous month was assessed. During this interview, food quantities were speci®ed in household measures. Usual portion sizes were estimated with the aid of portion size models or pictures of foods; frequently consumed portions of food and common household measures were weighed on a balance with a precision of 0.5 g. In addition, the subjects had previously completed a self-administered semi-quantitative validated foodfrequency questionnaire (FFQ), which was used as a cross check of the dietary history . The FFQ dealt speci®cally with the dietary intake of fat and antioxidants over the previous month. All types of food and drink were coded according to the system used by The Netherlands Nutrient Databank (NEVO), and subsequently converted into energy and nutrients by using the extended computerized version of the Netherlands Food Table  ( NEVO Foundation, 1989 . Intake of macronutrients and alcohol was expressed as percentage of energy intake (en%). Cholesterol and ®bre intakes were expressed as mgaMJ and as gaMJ, respectively.
3. Biochemical analyses. After subjects had fasted overnight, a venous blood sample (90 ml) was obtained and plasma and serum were stored at À80 C until analysed. Serum albumin, cholesterol, total protein, C-reactive protein (CRP), magnesium and whole blood thiamine were determined by routine methods in use at the hospital, on a Beckman Synchron CX 1 system (Brea, CA, USA). Serum prealbumin was measured using a radioimmunodiffusion technique (Beckman Immunochemistry systems, Brea, CA, USA). Serum vitamin B 12 and folic acid concentrations were assessed by means of a commercial kit (Quantaphase 1 B-12afolate Radioassay; Bio-RAD Laboratories B.V., Veenendaal, The Netherlands). Serum copper, zinc and selenium were determined by Zeeman-corrected electrothermal atomic absorption spectrometry. The assessment of whole blood activity of glutathione peroxydase was based on the method developed by Paglia and Valentine (1967) . Serum vitamins A and E (a-tocopherol) were determined with high pressure liquid chromatography (HPLC) and serum b-carotene by spectrophotometric assessment at 450 nm.
The concentration of vitamin E has been found to be closely related to serum lipids (Horwitt et al, 1972) , and the ratio of serum vitamin E to serum cholesterol was applied to accurately assess the vitamin E status in IBD patients.
4. Muscle strength. Prior to testing each subject underwent a 5 min warm-up period of aerobic ergometer cycling. The subjects were then ®xed to the testing apparatus, an Crohn's disease activity index (Best et al, 1979) . *Signi®cantly different from UC patients (one-Way ANOVA): P`0.05.
Nutritional status in IBD patients BJ Geerling et al isokinetic dynamometer (Cybex II, Eagle Performance Systems, Owatonna, Mn) (Gleeson & Mercer, 1996) . The strength of m. quadriceps (extension) and of the hamstrings (¯exion) were measured. They completed a few sub-maximal warm-up muscle actions at each angular velocity, and then ®ve maximal muscle actions. Peak torque was determined from a ®ve-fold measurement at velocities of 60 and 180 s
À1
. In addition, the¯exoraextensor ratio at each velocity was calculated.
Statistical analysis
Results were expressed as mean AE s.d. or as stated. Differences in nutritional status between IBD patients and controls were analysed using a paired Student's t-test. Correlation coef®cients and partial correlations were calculated by regression analysis. All statistical analyses were performed with the SPSS 7.0 for Windows package (SPSS Inc., Chicago, IL).
Results

Body composition
The body composition results of the subjects are shown in Table 2 .
CD patients
Patients were signi®cantly (P`0.05) taller than controls and FFM was signi®cantly higher in CD patients compared with controls. Furthermore, BMC was signi®cantly (P`0.05) lower in CD patients. We did not ®nd other signi®cant differences between patients and controls.
UC patients
Body weight and BMI were signi®cantly (P`0.05) lower in the total group of patients than in controls. Sex-speci®c analysis showed that alterations in body composition were predominantly observed in male UC patients. BMI was signi®cantly (P`0.01) lower in male patients (23.3 kgam 2 AE 2.9) than in controls (25.7 kgam 2 AE 3.2); 
Dietary intake
The subjects' mean daily nutrient intakes are shown in Table 3 .
CD patients
The mean daily total carbohydrate intake (en%) was signi®cantly (P`0.05) higher in CD patients at time of diagnosis than in controls (Table 3 ). This might be explained by a tendency of higher mono-and disaccharides intake in CD patients compared with controls (P 0.06). CD patients with high disease activity (CDAI b 150) showed a signi®cantly (P`0.025) higher total carbohydrate intake (56.4% AE 5.4) than CD patients in remission (48.7% AE 5.8). The difference in mono-and disaccharides intake between patients with active CD (31.1% AE 5.5) and patients with no disease activity (24.9% AE 6.1) did not reach signi®cance (P 0.08). PUFA and alcohol intakes (en%) were signi®cantly (P`0.05) lower in CD patients than in controls.
UC patients
The mean daily intake of total protein (en%), phosphorus, calcium, ribo¯avin and vitamin C were signi®cantly (P`0.05) lower in UC patients than in controls.
Biochemical analysis
The serum indexes of the subjects are shown in Table 4 .
CD patients
Serum albumin and vitamin B 12 concentrations were signi®cantly (P`0.05) lower in CD patients than in controls. The activity of the enzyme glutathione peroxydase was lower in CD patients compared with controls; however, this did not reach signi®cance (P 0.06). We found signi®cant correlations between cholesterol and b-carotene concentration (r 0.38, P 0.05) and vitamin E concentration (r 0.52, P 0.01).
UC patients
Serum albumin, b-carotene, magnesium, zinc and selenium concentrations were signi®cantly (P`0.05) lower in UC patients than in controls. The ratio of b-carotene to serum cholesterol concentration was signi®cantly (P`0.05) lower in UC patients (0.39 mmolag AE 0.14) than in controls (0.47 mmolag AE 0.17). The ratio of serum vitamin E concentration to cholesterol concentration did not signi®cantly differ between patients and controls. Signi®cant correlations were found between cholesterol and b-carotene concentration (r 0.58, P`0.001) and vitamin E (r 0.77, Nutritional status in IBD patients BJ Geerling et al P`0.001), respectively. A signi®cant correlation between concentration of zinc and albumin was observed in patients as well as in controls (r 0.41, P`0.01; r 0.33, P`0.01, respectively). We found a signi®cant correlation between the activity of glutathione peroxydase and selenium concentration in UC patients (r 0.39, P`0.01) but not in controls (r 0.10, P 0.53; Figure 1 ).
Muscle strength
The results of differential muscle strength measured with an isokinetic dynamometer are shown in Table 5 . We did not ®nd any signi®cant differences in peak torques of hamstrings or quadriceps muscles between patients and controls. The¯exoraextensor ratio at both velocities did not signi®cantly differ between patients and controls. Peak torque of the¯exor and extensor muscles correlated signi®cantly (P`0.01) with FFM estimated by DXA in both patient groups and controls (Figure 2 ).
Disease activity
Eighty-three percent of CD patients and 92% of UC patients were clinically in remission according to the CDAI criteria (CDAI`150) and Truelove and Witts criteria (Truelove and Witts`19) . One patient with active CD (CDAI ! 150) and one patient with active UC (Truelove and Witts ! 19) were treated with steroids.
Discussion
The present study showed that the nutritional status of IBD patients is already affected negatively at time of diagnosis. Nutritional status was assessed by four different measurements (body composition, dietary intake, biochemical indexes and muscle strength), all of which re¯ect the outcome of nutrition in a special way. IBD patients in the present study differ from controls concerning the four different measurements of the nutritional status, resulting in a deteriorated nutritional status. To our knowledge, the present study is the ®rst to report a comprehensive nutritional status in recently diagnosed IBD patients. Weight loss is often reported in IBD patients, especially in patients with active CD (Royall et al, 1995; Zurita et al, 1995; Kelly & Fleming, 1995; Tjellesen et al, 1998) . The signi®cantly higher body length of CD patients could explain the signi®cantly higher amount of FFM in these patients compared with controls. Hence, relative measurements of body composition, eg percentage body fat, are appropriate indicators of possible differences between CD patients and controls in the present study. However, no such differences were observed between CD patients and controls. This could also be due to the small number of patients studied, which may have induced a type II-error ( -error).
There are a few studies which evaluated body composition in UC patients (Capristo et al, 1998 (Capristo et al, , 1999a . These authors did not show any signi®cant differences regarding body composition parameters between patients with inac- Data are expressed as mean AE s.d. CD Crohn's disease; UC ulcerative colitis. Quadriceps muscle strength is measured by peak torque extension, and hamstring muscle strength by peak torque¯exion. Figure 2 Correlation between peak torque of hamstrings (¯exor) muscles measured at 60 s À1 and FFM (kg) estimated by DXA for controls (closed squares, semi dotted line; r 0.73, P`0.001), UC patients (open squares, straight line; r 0.72, P`0.001) and CD patients (closed triangles, dotted line; r 0.72, P`0.01), and correlation between peak torque of quadriceps (extensor) muscles measured at 60 s À1 and FFM (kg) estimated by DXA for controls (r 0.83, P`0.001), UC patients (r 0.81, P`0.001) and CD patients (r 0.80, P`0.01). FFM fat-free mass; DXA dual energy X-ray absorptiometry.
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BJ Geerling et al tive UC and controls, in contrast with results of our study. It should be noted, however, that the study population and the methods used differed from ours. We studied recently diagnosed UC patients, whereas the disease duration was longer in the studies of Capristo et al. Second, we used ageand sex-matched population controls and performed gender speci®c analyses of body composition changes, which may have increased the power of our study. Thirdly, in the studies of Capristo et al (1998 Capristo et al ( , 1999a body composition was measured by bioelectric impedance with the assumption of a constant BWaFFM ratio of 0.732. We showed in a previous study that body hydration of female IBD patients differs from that of controls (Geerling et al, 1999) . In the present study, the height of UC patients was comparable with controls and in this group we found a reduced body weight and body mass index compared with controls. Sexspeci®c analysis showed that the differences in body composition between male UC patients and controls contributed to the differences in body composition. These data are in line with our previous observation in which we showed that body composition differences were predominantly found between male patients with long-standing CD, clinically in remission and controls (Geerling et al, 1998a, b) . Some studies suggested that gender differences may play a role in the ef®ciency of energy metabolism under metabolic stress (Bjorntorp, 1989) . Furthermore, genderspeci®c hormonal responses after metabolic stress may be a possible mechanism for the observed sex differences in body composition (Cortright et al, 1997) . However, more studies in humans are necessary to elucidate the observed gender-speci®c differences concerning disease-induced alterations of body composition. The dietary energy intake of IBD patients in the present study did not differ from controls. The majority of the patients did not have a strongly elevated disease activity, which may explain their normal energy intake (Geerling et al, 1998a, b) . An interesting ®nding however, was the signi®cantly higher intake of total carbohydrates in CD patients compared with controls. Many studies have postulated that sugar intake may be a risk factor in the development of CD (Persson et al, 1992; Tragnone et al, 1995; Thornton et al, 1979; Reif et al, 1997) . It is suggested, however, that the greater consumption of sugars in CD patients may be a result rather than a cause of the disease. Furthermore, it was recently suggested by Riordon et al, that the reported increased current sugar intake of CD patients may be a consequence of active disease (Riordan et al, 1998) . In the present study, four CD patients scored a CDAI above 150, indicating active disease. The total carbohydrate intake expressed as percentage of energy was signi®cantly higher in the patients with high disease activity than in patients with a CDAI below 150. Furthermore, if the CD patients with high disease activity were excluded from the analyses, we did not ®nd signi®cant differences between the total carbohydrate or mono-plus disaccharides intakes between CD patients and controls. This is in line with studies which reported similar intakes of energy and sugars in CD patients in remission compared with randomly selected controls (Geerling et al, 1998a, b; Brauer et al, 1983) . It is known that sugar-containing foods are found to be more palatable, which may explain the high carbohydrate intake during active disease. It was suggested that zinc de®ciency may depress taste acuity, which may cause an increased sugar intake. However, studies were unable to show impaired taste acuity in CD patients (Penny et al, 1983 ).
Total energy intake was not found to be different between CD patients and controls. Dietary advice for CD patients is often to reduce their fat intake. In the present study we showed that the fat intake of CD was lower compared with controls, however not signi®cantly.
In UC patients, we found signi®cantly lower intakes of phosphorus, calcium, ribo¯avin and protein than in controls. This may be a contributing factor to the development of osteoporosis in UC patients because these nutrients are important in bone metabolism (Schoon et al, 1998) .
In a recent study, we reported that patients with longstanding CD, currently in remission, were at risk of developing nutritional de®ciencies, especially of antioxidants (Geerling et al, 1998a, b) . In the present study, we also found signi®cant reductions of several serum antioxidants (b-carotene, selenium and zinc), especially in UC patients. Serum selenium concentrations were signi®cantly correlated with the activity of glutathione peroxydase in UC patients, but not in controls. This suggests that the selenium requirement for enzyme activity was met in the majority of the controls and not in the UC patients (Rannem et al, 1992; Thomas et al, 1994) . The decrease in serum antioxidants of UC patients may be explained by increased consumption of antioxidants by the recently in¯amed tissue rather than by impaired digestion and absorption of nutrients, which is unlikely in UC patients. Studies showed that the antioxidant defence may be depleted by increased reactive oxidative species found in in¯amed mucosa of IBD patients (Simmonds & Rampton, 1993; Gross et al, 1994; Ramakrishna et al, 1997) . It is therefore possible that the antioxidant status in UC patients of the present study was not completely restored after the recent in¯ammation period. In CD patients, the reductions in serum antioxidants did not reach signi®cance, which could have been caused by a type II error.
The majority of the patients in the present study showed no strongly elevated disease activity; we found that 83% of CD patients and 92% of UC patients were clinically in remission during the study. Furthermore, the reported deteriorated antioxidant status in these patients, especially UC patients, could not be explained by a reduced dietary intake or smoking (15.2% of UC patients were current smokers vs 23.3% of matched controls).
The present data support the hypothesis that in IBD patients an imbalance exists between increased reactive oxidative species production and reduced antioxidant defences with regard to the pathogenesis of tissue injury in IBD (Grimble, 1994; Verspaget et al, 1991; Conner & Grisham, 1996) . In a recent study, we were able to improve the antioxidant status of patients with long-standing CD, clinically in remission, by 3 months' supplementation with antioxidants andaor n-3 fatty acids in addition to their regular diet (Geerling et al, 1998a, b) . However, it needs to be elucidated whether improvement of antioxidant status by supplementation is bene®cial for the clinical course of IBD.
Vitamin B 12 de®ciency is frequently observed in CD patients, however rarely in UC patients (Zurita et al, 1995; Kelly & Fleming, 1995) . In the present study, we also found that vitamin B 12 was signi®cantly lower in CD patients compared with controls, however, no differences were found between UC patients and controls. Vitamin B 12 is absorbed in the distal ileum, and it is generally thought that malabsorption of this vitamin occurs due to ileal resection or after prolonged small bowel in¯ammation Nutritional status in IBD patients BJ Geerling et al (Harries & Heatley, 1983) . The present study showed that each CD patient, even at time of diagnosis, requires serious attention concerning vitamin B 12 status.
It has been shown that skeletal muscle function seems to be sensitive indicator of nutritional status in patients (Lopes et al, 1982) , as functional changes occurred before abnormalities in conventional indices of malnutrition were observed (Cristie & Hill, 1990; Russell et al, 1983) . In patients with long-standing CD, currently in remission, we observed a signi®cantly reduced strength of the hamstring muscles (with a high percentage of type IIb ®bres), whereas the strength of the quadriceps muscles was preserved (Geerling et al, 1998a, b) . It is known that corticosteroids therapy and also malnutrition may induce selective type IIb ®bre atrophy (Russell et al, 1983; van Balkom et al, 1994) . Furthermore, malnutrition is associated with altered energy generation in the mitochondria (ie impaired rephosphorylation of ADP in the muscle) (Mijan de al Torre et al, 1993) and with relative loss of muscle creatine and phosphorus in relation to ATP (Thompson et al, 1998) . Jeejeebhoy suggested that ATP generation in muscle may be abnormal despite normal body composition in these patients (Jeejeebhoy, 1998) . In the present study, muscle strength was not signi®cantly different between IBD patients and controls. This suggests that in the patients at time of diagnosis, muscle strength is not yet affected. Malnutrition and steroid use may affect muscle strength as the disease progresses. Physical ®tness may also alter muscle strength. Physical activity of patients and controls was not taken into account in our study, however, none of the patients was hospitalized during the study and both patients and controls were sedentary, with few of them performing regular physical activity. Further studies are required to elucidate the effect of malnutrition, corticosteroid therapy and physical activity on the selective reduction in muscle function of IBD patients.
This study revealed that IBD patients at time of diagnosis were already at risk of developing several nutritional de®ciencies, especially of antioxidants. Nutritional status was comprehensively assessed in four different dimensions. More research is needed to elucidate the effect of nutritional supplementation on the clinical course of patients with recently diagnosed IBD.
